SUBSCRIBE
SUBSCRIBE

Asia

Pharm Country
Merck and Hanmi Ink $870 Million NASH Deal
Merck entered into an exclusive licensing deal with Hanmi Pharmaceutical for the development, manufacture and commercialization of efinopegdutide for nonalcoholic steatohepatitis (NASH).
August 4, 2020
 · 
2 min read
 · 
Mark Terry
Policy
Biopharma Update on the Novel Coronavirus: August 3
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for August 3, 2020.
August 3, 2020
 · 
3 min read
 · 
BioSpace Editorial Staff
Business
Regeneron and BioNTech Partner on Immunotherapy Combo for Melanoma
Regeneron Pharmaceuticals and BioNTech have inked a strategic collaboration to combine BioNTech’s BNT111 FixVac product candidate and Regeneron and Sanofi’s checkpoint inhibitor Libtayo (cemiplimab) for the treatment of melanoma.
August 3, 2020
 · 
2 min read
 · 
Mark Terry
Drug Development
Clinical Catch-Up: July 27-31
As usual, there was plenty of clinical trial news last week. Here’s a look.
July 31, 2020
 · 
6 min read
 · 
Mark Terry
Business
BioSpace Movers & Shakers, July 31
Biopharma and life science companies strengthen their leadership teams and board with these Movers & Shakers.
July 30, 2020
 · 
6 min read
 · 
Alex Keown
Policy
Biopharma Update on the Novel Coronavirus: July 31
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 31, 2020.
July 30, 2020
 · 
4 min read
 · 
BioSpace Editorial Staff
BioSpace Global Roundup, July 30
Biopharma and life sciences companies from across the globe provide updates on their pipelines and businesses.
July 29, 2020
 · 
5 min read
 · 
Alex Keown
Policy
Biopharma Update on the Novel Coronavirus: July 29
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 29, 2020.
July 29, 2020
 · 
5 min read
 · 
BioSpace Editorial Staff
Business
AstraZeneca and Daiichi Sankyo Ink $6 Billion Cancer Pact
AstraZeneca inked a global development and commercialization deal with Daiichi Sankyo Company for DS-1062, a trophoblast cell-surface antigen 2 (TROP2)-directed antibody drug conjugate (ADC) for multiple cancer types.
July 27, 2020
 · 
3 min read
 · 
Mark Terry
Policy
Biopharma Update on the Novel Coronavirus: July 27
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 27, 2020.
July 24, 2020
 · 
2 min read
 · 
BioSpace Editorial Staff
Load More
PRESS RELEASES
Press Releases
ImmunityBio Partners with Biopharma and Cigalah Healthcare to Launch ANKTIVA® in Saudi Arabia for Bladder and Lung Cancer Patients
February 20, 2026
 · 
10 min read
Press Releases
Daiichi Sankyo Appoints John Tsai, MD as Global Head of R&D
February 19, 2026
 · 
2 min read
Press Releases
Positive Phase 3 Data Demonstrate Potential for ENTYVIO® (vedolizumab) to Address Treatment Gap for Children and Adolescents with Moderate to Severe Ulcerative Colitis
February 19, 2026
 · 
16 min read
Press Releases
YolTech Therapeutics Announces Positive Interim Data on YOLT-202 for the Treatment of Alpha-1 Antitrypsin Deficiency
February 19, 2026
 · 
4 min read
Press Releases
ENHERTU® Type II Variation Application Validated in the EU as Post-Neoadjuvant Treatment for Patients with HER2 Positive Early Breast Cancer
February 19, 2026
 · 
10 min read
Press Releases
Nyxoah Announces the Signature of a Memorandum of Understanding with Sheikh Shakhbout Medical City Hospital to Improve OSA Therapy Management and Accelerate Access to Genio in the Middle East
February 18, 2026
 · 
6 min read
Press Releases
Asahi Kasei Pharma and Alchemedicine Advance a Novel Therapeutic Candidate Into Phase I Study for the Treatment of Refractory Diseases
February 18, 2026
 · 
3 min read
Press Releases
Catalent and S.Biomedics Announce Partnership to Develop and Manufacture TED‑A9
February 18, 2026
 · 
3 min read
Press Releases
Pluri Secures Global IP Position with China Patent Grant for Large-Scale Immune Cell Expansion, Complementing Prior U.S. Patent
February 18, 2026
 · 
6 min read
Press Releases
Vietnam Approves Biomerica’s EZ Detect™ for Nationwide Distribution
February 18, 2026
 · 
8 min read
Press Releases
Adagene to Participate in Two Upcoming Investor Conferences - February 17, 2026
February 17, 2026
 · 
3 min read
Press Releases
Moleculin Announces Notice of Allowance for Japanese Patent Covering Annamycin
February 17, 2026
 · 
5 min read
Press Releases
Deciphera Pharmaceuticals Announces U.S. Food and Drug Administration Acceptance for Filing of New Drug Application for Tirabrutinib in Patients with Relapsed or Refractory PCNSL
February 17, 2026
 · 
6 min read
Press Releases
Juvenescence appoints Eileen Jennings-Brown as Chief Technology Officer and strengthens presence in UAE with new partnership and facilities with Masdar City
February 16, 2026
 · 
5 min read
Press Releases
New ECCO data show subcutaneous (SC) infliximab (Remsima™ SC) effectively recaptures and maintains disease control after drug holiday
February 16, 2026
 · 
7 min read
Press Releases
CStone Announces FDA Clearance of IND Application for Its Novel Trispecific Antibody CS2009 (PD-1/VEGF/CTLA-4) to Advance into Phase II Clinical Trial
February 16, 2026
 · 
4 min read
Press Releases
Altamira Therapeutics Announces Allowance of Japanese Patent Application Covering Bentrio Nasal Spray
February 13, 2026
 · 
5 min read
Press Releases
Advanced Biomed Inc. Announces 120‑Case Feasibility Study with Chi‑Mei Medical Center to Validate A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery
February 13, 2026
 · 
5 min read
Press Releases
STADA and Bio-Thera receive European Marketing Authorization for Gotenfia, a Biosimilar to Simponi
February 13, 2026
 · 
7 min read
Press Releases
World-First EXO 001 Exosome Platform Enables In Vivo Multi-Target CAR-T for Solid Tumors
February 13, 2026
 · 
5 min read
Load More